|
ARL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.811750E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.080520E-03 |
| Normal-vs-Stage2 |
8.738400E-02 |
| Normal-vs-Stage3 |
2.37220000000038E-05 |
| Normal-vs-Stage4 |
3.99570000000349E-05 |
| Stage1-vs-Stage2 |
3.776600E-01 |
| Stage1-vs-Stage3 |
9.300100E-02 |
| Stage1-vs-Stage4 |
9.665500E-02 |
| Stage2-vs-Stage3 |
5.544200E-02 |
| Stage2-vs-Stage4 |
4.786300E-02 |
| Stage3-vs-Stage4 |
7.151600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1943999999996E-05 |
| Normal-vs-AfricanAmerican |
1.847230E-01 |
| Normal-vs-Asian |
3.818500E-04 |
| Caucasian-vs-AfricanAmerican |
1.436780E-01 |
| Caucasian-vs-Asian |
9.448600E-01 |
| AfricanAmerican-vs-Asian |
1.940350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.88320000000087E-05 |
| Normal-vs-Female |
7.243300E-04 |
| Male-vs-Female |
1.428980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.232200E-04 |
| Normal-vs-Age(41-60Yrs) |
9.784200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.249000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.521200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.637200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.883400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.389000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.987600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.004200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.270200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.075600E-02 |
| Classical-VS-Follicular |
3.157200E-01 |
| Classical-VS-Other |
1.457960E-01 |
| Classical-VS-Normal |
3.561200E-04 |
| Tall-VS-Follicular |
2.810300E-02 |
| Tall-VS-Other |
3.967800E-01 |
| Tall-VS-Normal |
6.10030000000039E-05 |
| Follicular-VS-Other |
1.578390E-01 |
| Follicular-VS-Normal |
6.481900E-02 |
| Other-VS-Normal |
8.361500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.655630E-03 |
| Normal-vs-N1 |
1.47770000002989E-06 |
| N0-vs-N1 |
1.654210E-02 |
|
|
